Chemed Corporation (CHE) Tops Q2 EPS by 46c
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $512.16 +3.33%
Revenue Growth %: +9.5%
Financial Fact:
Total costs and expenses: 349.74M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +9.5%
Financial Fact:
Total costs and expenses: 349.74M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Chemed Corporation (NYSE: CHE) reported Q2 EPS of $6.06, $0.46 better than the analyst estimate of $5.60. Revenue for the quarter came in at $673.25 million versus the consensus estimate of $665.04 million.
For earnings history and earnings-related data on Chemed Corporation (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- NeuroSense posts narrower H1 loss, targets Canada drug filing by December
- ShinyHunters hackers say they stole psychiatric and medical records of DBI staff - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
